Jessie De Bie

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples (March – October 2020)

Sereina A. Herzog, Jessie De Bie, Steven Abrams et al. · medRxiv · 2020 · 85 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020

Sereina A. Herzog, Jessie De Bie, Steven Abrams et al. · Eurosurveillance · 2022 · 78 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Alpha-linolenic acid protects the developmental capacity of bovine cumulus–oocyte complexes matured under lipotoxic conditions in vitro†

Waleed F. A. Marei, Jessie De Bie, Omnia Mohey‐Elsaeed et al. · Biology of Reproduction · 2017 · 63 citations · Full text

Life Sciences, Animal Sciences, Nutritional Sciences +17

The effect of a negative energy balance status on β-carotene availability in serum and follicular fluid of nonlactating dairy cows

Jessie De Bie, A. Langbeen, Annelies Verlaet et al. · Journal of Dairy Science · 2016 · 33 citations · Full text

Agriculture, Animal Sciences, Dairy Science +11